Synthetic Biomarkers Detect Ovarian Cancer

News   Apr 10, 2017 | Original Story from MIT

 
Synthetic Biomarkers Detect Ovarian Cancer
 
 
 

RELATED ARTICLES

BioAscent Establishes Integrated Drug Discovery Services Offering

News

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.

READ MORE

Lab Innovations returns to the NEC, Bimingham , UK

News

Save the date for the UK’s only lab-dedicated exhibition showcase!

READ MORE

Antibody Drug-Conjugate to Target Treatment-Resistant Childhood Leukemia

News

Researchers have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia. Using a novel approach, early testing shows that targeting the protein with an antibody drug conjugate (ADC) could hold promise in improving treatment.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE